AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $625,523 | +81.8% | 41,841 | 0.0% | 0.01% | +62.5% |
| Q3 2022 | $344,000 | +25.5% | 41,841 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $274,000 | +17.1% | 41,841 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $234,000 | +19.4% | 41,841 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $196,000 | -24.3% | 41,841 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $259,000 | -4.8% | 41,841 | +1.2% | 0.01% | 0.0% |
| Q2 2021 | $272,000 | -19.8% | 41,343 | -10.8% | 0.01% | -28.6% |
| Q1 2021 | $339,000 | +26.5% | 46,327 | 0.0% | 0.01% | +16.7% |
| Q4 2020 | $268,000 | +8.9% | 46,327 | +12.1% | 0.01% | 0.0% |
| Q3 2020 | $246,000 | +15.5% | 41,343 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $213,000 | +42.0% | 41,343 | 0.0% | 0.01% | +20.0% |
| Q1 2020 | $150,000 | – | 41,343 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |